M·CAM | News Archive
54
archive,paged,category,category-news-archive,category-54,paged-3,category-paged-3,ajax_fade,page_not_loaded,,select-theme-ver-4.1,wpb-js-composer js-comp-ver-7.9,vc_responsive

House Judiciary Committee Approves Goodlatte Patent Reform Bill by Overwhelming, Bipartisan Vote

Date:  Thu, 2015-06-11

Washington, D.C. – The House Judiciary Committee today approved the Innovation Act (H.R. 9) by an overwhelming vote of 24-8. This bipartisan bill takes steps to combat the ever increasing problem of abusive patent litigation. The legislation addresses abusive practices taking place in our courts.

House Judiciary Committee Chairman and chief sponsor of the Innovation Act Bob Goodlatte (R-Va.), praised today’s Committee vote.

Chairman Goodlatte: “At its core, abusive patent litigation is a drag on our economy and stifles innovation. It is a problem that impacts businesses and industries of all types and the jobs of the people who work for them, from the tech sector to the hospitality industry and even grocery stores. Everyone from independent inventors, to start-ups, to mid-and large-sized businesses face this constant threat. The tens of billions of dollars squandered on settlements and litigation expenses associated with abusive patent suits represent truly wasted capital – capital that could have been used to create new jobs, fund research and development, and create new innovations and technologies.

“The Innovation Act takes the necessary steps to address abusive patent litigation, while protecting legitimate property rights. Specifically, the legislation targets abusive behavior rather than specific entities, preserves valid patent enforcement tools, preserves patent property rights, promotes invention by independents and small businesses, and strengthens the overall patent system.”

Key Components of the Innovation Act:

Targets Abusive Patent Litigation: The bill targets abusive patent litigation behavior and not specific entities with the goal of preventing individuals from taking advantage of gaps in the system to engage in litigation extortion. It does not attempt to eliminate valid patent litigation.

Protects the Patent System: This legislation does not diminish or devalue patent rights in any way.

Increases Transparency: This legislation requires greater transparency in patent litigation and requires parties to explain exactly why they are suing a business or individual. Requiring parties to do a bit of due diligence up front before filing an infringement suit is just plain common sense. It not only reduces litigation expenses, but saves the court’s time and resources. Greater transparency and information is a good thing and it makes our patent system stronger.

Prevents Extortion: The legislation prevents any one party in a patent lawsuit from unilaterally racking up extreme litigation costs for another party in an attempt to force a dubious settlement.

Provides Greater Clarity: The legislation provides for more clarity surrounding initial discovery, case management, joinder and the common law doctrine of customer stays. The bill works hand-in-hand with the procedures and practices of the Judicial Conference and the courts.

Small Business Education: The bill provides for small business education and outreach by the U.S. Patent and Trademark Office.

Places Reasonable Limits on Venue in Patent Cases: Restores Congress’s intent that patent infringement suits only be brought in judicial districts that have some reasonable connection to the dispute. Since 1897, Congress has regulated the venue in which patent actions may be brought. These limits protect parties against the burden and inconvenience of litigating patent lawsuits in districts that are remote from any of the underlying events in the case. In 1990 the U.S. Court of Appeals for the Federal Circuit “reinterpreted” that statute in a way that robbed it of all effect. The Innovation Act corrects the Federal Circuit’s error, and restores the congressional purpose of placing some reasonable limits on the venue where a patent action may be brought.

Reduces Unnecessary, Expensive Discovery: Requires that courts stay discovery in a patent case when a motion to dismiss or a motion to transfer has been filed. This will help parties avoid expensive, wasteful discovery that might otherwise be used as leverage by patent trolls looking for a quick settlement when a case can be resolved quickly and early.

VIDEO: Learn more about the importance of protecting and promoting American innovation by curbing abusive patent litigation by clicking HERE

M·CAM releases Patently Obvious® on Avago Technologies Suing Maxim Integrated Products

Date:  Wed, 2015-06-10

M·CAM releases Patently Obvious® on Avago Technologies Suing Maxim Integrated Products.

On April 23rd, 2015, Avago Technologies General IP (Singapore) PTE. LTD filed suit against Maxim Integrated Products, Inc. regarding their semiconductor devices. Avago claims that Maxim infringes on five patents (US 5,523,359; US 5,599,739; US 6,040,616; US 6,083,271; and US 6,194,323) when manufacturing its MAX6946, MAX2634, MAX7356, MAX17126, DS28E10, MAX1305, and other semiconductor products. Maxim had, for nearly two decades, licensed semiconductor technologies from LSI Corporation’s patent portfolio. The license to these technologies lapsed on December 31, 2011. Avago acquired LSI in 2014, and claims that Maxim has continued to benefit from the technologies represented by the LSI portfolio. These technologies broadly cover methods for improved integrated circuit fabrication and design, including hard mask etching, barrier layer treatment, and specifying multiple power domains.

M·CAM’s Patently Obvious® is a report providing visibility into potentially unconsidered alternatives, including art in the public domain, to patent holdings across a variety of technology areas.

M·CAM is a global, full-service intellectual property and rights (IP&R) and intangible asset financial services firm. We provide the technical and financial systems that allow public and private markets to use IP&R and IA for regulated transactions in banking, securities, insurance, and public innovation investment and technology procurement. From our pioneering work in creating the world’s first standards-based innovation collateralization financial products for banking and securities to our work in grassroots innovator enablement and patent quality assurance programs, M·CAM provides the mechanism to balance the interests of public and commercial sectors to support and build thriving economies.

The M·CAM Patently Obvious® on Avago Technologies Suing Maxim Integrated Products can be found HERE.

M·CAM releases Patently Obvious® on How Attractive is Chimerix

Date:  Wed, 2015-06-10

M·CAM releases Patently Obvious® on How Attractive is Chimerix

While Chimerix’s fully owned patent portfolio is fairly small, a number of licensing agreements have allowed the company to develop beyond its own proprietary technology. Combining in-house and licensed patents gives Chimerix a strong exclusivity position if its CMX001 and CMX157 candidates pass through clinical trials. With no glaring prior art problems and strong third-party interest in its technology, the market may be overweighting Chimerix’s IP risk. M·CAM believes the company’s IP risk is lower than industry average, which should allow for a clean product launch and make Chimerix an attractive acquisition target for Gilead, Novartis, and other large pharma players.

M·CAM’s Patently Obvious® is a report providing visibility into potentially unconsidered alternatives, including art in the public domain, to patent holdings across a variety of technology areas.

M·CAM is a global, full-service intellectual property and rights (IP&R) and intangible asset financial services firm. We provide the technical and financial systems that allow public and private markets to use IP&R and IA for regulated transactions in banking, securities, insurance, and public innovation investment and technology procurement. From our pioneering work in creating the world’s first standards-based innovation collateralization financial products for banking and securities to our work in grassroots innovator enablement and patent quality assurance programs, M·CAM provides the mechanism to balance the interests of public and commercial sectors to support and build thriving economies.

The M·CAM Patently Obvious® on How Attractive is Chimerix can be found HERE

Celgene’s Revlimid® Patents Do Not Withstand Review

FOR IMMEDIATE RELEASE

Celgene’s Revlimid® Patents Do Not Withstand Review

CHARLOTTESVILLE, VA – On May 7, 2015, the European Patent Office revoked one of Celgene’s (NASDAQ: CELG) patents on Revlimid®. Revlimid® reportedly accounts for almost $5 billion of Celgene’s nearly $7.5 billion in annual revenue and is approved by the U.S. Food and Drug Administration (FDA) for the treatment of cancer and other autoimmune diseases.

A systematic and rigorous review of the available precedent information, undertaken by M·CAM, provides a sound basis for the invalidation of many other Revlimid® patents, including those currently listed in the FDA’s Orange Book, on the grounds that they are based on an older drug and that the use of the drug in the treatment of cancer was obvious. If the invalidation of the entire Revlimid® portfolio were systematically pursued by a third party, it could materially and adversely impact Celgene.

Simply put, the core Revlimid® compound patent, U.S. Pat. No. 5,635,517 (‘517), is and has always been based on an old drug (thalidomide) and the “innovations” on which Revlimid is based, going back to its priority date in 1996, are obvious in light of precedent innovation. As a result, the ‘517 patent should not be entitled to patent protection in the United States or any of the nearly 70 countries where Revlimid® is approved. Since this base patent of the Revlimid® families of patents is not valid, then many of the Revlimid® patents are subject to validity or commercial relevance challenges.

The full report can be found at Harvest Exchange.

About M·CAM

M·CAM is a global financial institution that advises corporations and investors on corporate finance and asset allocation by underwriting intellectual property (IP) and intangible assets (IA). From its roots in providing financial products enabling lenders to use IP and IA as regulatory acceptable collateral for lending, M·CAM’s capital solutions address the financial needs of businesses and investors in the Knowledge Economy. M·CAM has been providing capital markets solutions to financial, sovereign, and corporate institutions since its inception in 1998.

contact@m-cam.com
210 Ridge-McIntire Road
Charlottesville, VA 22902
www.m-cam.com
434-979-7240

M·CAM Inc. presents Mechanics of Consciousness and The Metamoney Artifact RVU, an exhibition by Dylan Korelich

Date:  Tue, 2015-04-21

Mechanics of Consciousness and The Metamoney Artifact RVU April 21, 2015 – May 24, 2015

M·CAM Inc. is pleased to present Mechanics of Consciousness and The Metamoney Artifact RVU, an exhibition by Dylan Korelich. This series of oil paintings explores and continues the dialog between art, religion, science and esoteric symbolism. It is a narrative that employs the aesthetics and techniques of the old masters and the argument of form presented in modern abstract painting. The impulse is to revisit the questions of rationalism and empiricism in the dawn of a world where the artifact maybe reduced to a coded reconstruction in brain computer interface technology (BCI) and augmented reality applications. It questions what does it mean to be conscious? How do we form our values? And is it possible to capture our experience through the lens of an objective observer?

The Metamoney Artifact RVU is working symbol and it’s memory of transaction are a testament to a working model of value exchange using the principles of Integral Accounting. Rather than denominating an impulse to conclude and thereby terminate a relationship between transacting parties, it serves as a token of remembrance of the provision and receipt of value. As it can fulfill this function in any environment for any purpose, the RVU has placed the responsibility of stewardship and remembrance on all parties engaging with it.

To read more about the exhibition, Click HERE

M·CAM Chairman Dr. David Martin Feautured on Last Week Tonight with John Oliver

Date:  Mon, 2015-04-20

CHARLOTTESVILLE, VA April 20, 2015- M·CAM Chairman Dr. David Martin Featured on Last Week Tonight with John Oliver

Last Week Tonight with John Oliver featured M·CAM Chairman, Dr. David Martin, on a segment discussing patent trolls and patent troll reform legislation on April 19, 2015. The video featured Dr. Martin discussing the failure of the Innovation Act (H.R. 3309) in the United States Senate on Bloomberg West which originally aired May 23, 2014. In the clip, Cory Johnson asks Dr. Martin, “What do you make of this bill getting killed?” Dr. Martin responds, “Well, I know this is news but trial lawyers’ influence in Washington is alive and well.”

M·CAM releases Patently Obvious® on Potential Impairments to the Nokia Acquisition of Alcatel-Lucent

Date:  Thu, 2015-04-16

CHARLOTTESVILLE, VA April 16, 2015- M·CAM released its Patently Obvious® on Potential Impairments to the Nokia Acquisition of Alcatel-Lucent

On April 15, 2015, it was announced Nokia (NOK) plans to acquire Alcatel-Lucent (ALU). Despite market excitement that NOK will become a networking giant big enough to take on Ericsson, M&A enthusiasts have overlooked one glaring detail: part of ALU’s technology is restricted from transfer without the express consent of the U.S. Government’s security agencies, including parts of its patent portfolio.

M·CAM’s Patently Obvious® is a report providing visibility into potentially unconsidered alternatives, including art in the public domain, to patent holdings across a variety of technology areas.

M·CAM is a global, full-service intellectual property and rights (IP&R) and intangible asset financial services firm. We provide the technical and financial systems that allow public and private markets to use IP&R and IA for regulated transactions in banking, securities, insurance, and public innovation investment and technology procurement. From our pioneering work in creating the world’s first standards-based innovation collateralization financial products for banking and securities to our work in grassroots innovator enablement and patent quality assurance programs, M·CAM provides the mechanism to balance the interests of public and commercial sectors to support and build thriving economies.

The M·CAM Patently Obvious® on potential impairments to the Nokia acquisition of Alcatel-Lucent can be found HERE.

M·CAM releases Patently Obvious® on the PTAB Review of Allergan Patents

Date:  Fri, 2015-04-10

CHARLOTTESVILLE, VA April 10, 2015- M·CAM released its Patently Obvious® on the PTAB Review of Allergan Patents.

Multinational pharmaceutical firm Allergan is facing a patent review challenge before the USPTO’s Patent Trial and Appeal Board (PTAB). The inter partes review (IPR), brought by New York-based hedge fund Ferrum Ferro Capital, challenges the validity of one of Allergan’s patents that protects the glaucoma drug Combigan®. As we reported in our last Patently Obvious®, released on March 19, this and other IPR cases are being brought as part of a new investment strategy that aims to profit from patent invalidations against large pharmaceutical companies.

M·CAM’s Patently Obvious® is a report providing visibility into potentially unconsidered alternatives, including art in the public domain, to patent holdings across a variety of technology areas.

M·CAM is a global, full-service intellectual property and rights (IP&R) and intangible asset financial services firm. We provide the technical and financial systems that allow public and private markets to use IP&R and IA for regulated transactions in banking, securities, insurance, and public innovation investment and technology procurement. From our pioneering work in creating the world’s first standards-based innovation collateralization financial products for banking and securities to our work in grassroots innovator enablement and patent quality assurance programs, M·CAM provides the mechanism to balance the interests of public and commercial sectors to support and build thriving economies.

The M·CAM Patently Obvious® report on the PTAB Review of Allergan Patents can be found HERE.

M·CAM Chairman Dr. David Martin Scheduled on Film Panel at the RiverRun International Film Festival Screening of The Patent Wars

Date:  Wed, 2015-04-08

Dr. David Martin will be on a panel to discuss The Patent Wars after the screening of the film on April 22 in Winston Salem NC. The RiverRun International Film Festival has curated 74 feature films and 91 short films for the 2015 festival. Together with Producer Volker Ulrich, he will be discussing the documentary film written and directed by Hannah Leonie Prinzler which has been awarded Prêmio do Júri – Melhor Documentário at the International Film Festival in Sao Paulo, Brazil, and has been selected for Prix Europa, Mill Valley Film Festival, Starz Denver Film Festival, Marda Loop Justice Film Festival.

For tickets: https://uncsa.secure.force.com/ticket/#sections_a0FF000000JAtM6MAL

M·CAM Releases Quick Look Report on Cytec Industries

Date:  Mon, 2015-03-30

CHARLOTTESVILLE, VA March 30, 2015- M-CAM Releases Quick Look Report on Cytec Industries

“Compared to its competitors, DOW, DD,and HXL, CYT’s innovation seems fairly weak. DOW’s and DD’s innovation on mining chemicals has tighter market controls than CYT’s In Process Separation segment. CYT’s portfolio is also aging at a rapid pace and it is lacking patent coverage in key markets, including Brazil, China, and India, where spending is increasing in mining and defense. It is vital that CYT improves its proprietary controls in these markets in order to control pricing and keep margins strong.”

M·CAM is a global, full-service intellectual property and rights (IP&R) and intangible asset financial services firm. We provide the technical and financial systems that allow public and private markets to use IP&R and IA for regulated transactions in banking, securities, insurance, and public innovation investment and technology procurement. From our pioneering work in creating the world’s first standards-based innovation collateralization financial products for banking and securities to our work in grassroots innovator enablement and patent quality assurance programs, M·CAM provides the mechanism to balance the interests of public and commercial sectors to support and build thriving economies.

The Quick Look report on Cytec Industries can be found HERE.

M·CAM IP Advisory Role Included in Exide Technologies Plan to Emerge from Chapter 11

Date:  Mon, 2015-03-30

M·CAM is pleased with the confirmation of the Plan of Reorganization approved in the United States Bankruptcy Court for the District of Delaware on March 27, 2015 by the Honorable Kevin J. Carey (Case No. 13-11482). This plan includes direct reference to the important work that M·CAM has conducted over the past year highlighting the considerable opportunities afforded by Exide’s extensive IP and intangible asset estate. In section 6.18 of the approved plan, M·CAM’s involvement is confirmed to “pursue monetization of intellectual property through offset or similar transactions that are identified by the Reorganized Debtor.” http://www.exiderestructuringinfo.com/pdflib/3423_11482.pdf

Dr. Martin to Address the Islamic Food and Nutrition Council of America 17th International Halal Food Conference in Chicago.

Date:  Fri, 2015-03-20

M·CAM Chairman Dr. David E. Martin will deliver a keynote address on Islamic Finance and Global Trade at the 17th International Halal Food Conference April 13-15 in Schaumburg, Illinois. Dr. Martin has been an Advisory Board member of the U.S. Halal Association for several years and has advocated for multi-lateral dialogue and engagement on Halal finance and trade in the global market. Recognizing the principles of ethical commercial and social engagement, Dr. Martin will address the importance of integrity, transparency, and mutual benefit linked to productivity as the cornerstone to develop robust business around the world.

Dr. David Martin and The Unstoppables featured on the cover of CEO Magazine.

Date:  Fri, 2015-03-20

On 25 January 2015, the future of Australian business changed. The country’s sharpest entrepreneurs, investors, and business leaders embarked on a powerful journey to the Earth’s southernmost continent, Antarctica. They were boldly dubbed the ”˜Unstoppables’.

Unstoppables An Ecosystem for Entrepreneurs. Brazilian self-made millionaire Julio De Laffitte founded the Unstoppables movement with the aim to raise the financial intelligence of Australia and ignite entrepreneurial spirit. He worked closely with co-founder and project director Priscila Duarte to encourage more than 100 elite business brains from a diverse range of sectors to travel to one of the harshest yet most beautiful and awe-inspiring places in the world for an 11-day think tank.

The location ensured attendees, including myself, were removed from daily distractions, allowing networking between savvy entrepreneurs, millionaire business leaders, and industry heavyweights and inspiring radical thinking. We participated in a series of workshops hosted by top-flight facilitators and corporate leaders to foster fresh concepts and come back with the energy to ultimately shape the future of Australian business.

Similar to the Australian business environment, it wasn’t long before we were required to adapt. Mother Nature had thrown us a curve ball, delaying our adventure by several days due to poor weather; however, we showed resilience and persistence to finally achieve our goal and get to our destination. These qualities, and everything else we were to discover and take in, would prove to be just as relevant to our professional spheres back home as they were in Antarctica. – See more at: http://www.theceomagazine.com.au/news/ecosystem-entrepreneurs.html#sthas…

M·CAM Releases Patently Obvious® on The Financial Uncertainties of Patent Rules Changes

Date:  Thu, 2015-03-19

CHARLOTTESVILLE, VA March 19, 2015- M·CAM released its Patently Obvious® on The Financial Uncertainties of Patent Rules Changes.

The Leahy-Smith America Invents Act, Public Law 112-29, provides a series of new post-grant challenges to patent validity and enforcement. A series of material rulings from the United States Supreme Court over the past five years that narrow the scope of patentable subject matter and expand the grounds of patent claims rejections for obviousness have directly impacted the patent approval process. Inter Partes Review, Covered Business Method patent review, and new methods of Post-Grant Review, which comprise new jurisdiction for the Patent Trial and Appeal Board (PTAB), are dramatically altering the allowance of patentable inventions in the United States.

One company that is attempting to capitalize on these new avenues for post-grant patent review is Dallas’ Hayman Capital Management. In February, The New York Times reported that the hedge fund is specifically targeting large pharmaceutical companies with a combined market capitalization of $450 billion for Inter Partes Review based on patent obviousness. Hayman founder Kyle Bass was quoted in a report by Reuters as saying that Hayman’s strategy is “”¦to challenge and invalidate patents through the IPR process … (and) we are not going to settle.”

Hayman and other investors seem to believe that pharmaceuticals are the industry most impacted by the changes to PTAB review provided for under the America Invents Act. M·CAM’s Patently Obvious report demonstrates that there is in fact a much broader set of impacts across a variety of sectors. M·CAM measures precisely which companies are being hit with patentability rejections and subsequently have adverse cashflow effects. These measurements demonstrate an unconsidered effect on markets which may be used to advantageously predict the reduction or loss of proprietary cashflows and erosion of competitive positions.

M·CAM’s Patently Obvious® is a report providing visibility into potentially unconsidered alternatives, including art in the public domain, to patent holdings across a variety of technology areas.

M·CAM is a global, full-service intellectual property and rights (IP&R) and intangible asset financial services firm. We provide the technical and financial systems that allow public and private markets to use IP&R and IA for regulated transactions in banking, securities, insurance, and public innovation investment and technology procurement. From our pioneering work in creating the world’s first standards-based innovation collateralization financial products for banking and securities to our work in grassroots innovator enablement and patent quality assurance programs, M·CAM provides the mechanism to balance the interests of public and commercial sectors to support and build thriving economies.

The M·CAM Patently Obvious® report on The Financial Uncertainties of Patent Rules Changes can be found HERE.

M-CAM Business Partnership with Amusement Park Entertainment expands with DGWB Tie Up.

Date:  Thu, 2015-03-05

Advertising veteran Jimmy Smith is adding something new to the mix of his mini-media “conglomerate” — traditional advertising.

In 2011, the TBWA and Wieden & Kennedy vet known for such projects as Nike “Battlegrounds” and Gatorade “Replay” launched his own transmedia venture, Amusement Park Entertainment with a minority backing from IPG. Since then, under the Amusement Park umbrella he’s added companies focusing on music, sports and technology. Now he’s broadening the scope with the launch of Amusement Park Brands, a full-service agency.

The company will serve as the branding and marketing division of the Amusement Park family and results from a partnership with and the rebranding of Santa Ana, Calif.-headquartered agency DGWB Advertising & Communications. Mr. Smith has teamed with DGWB partners Mike Weisman and Jon Gothold as well as former DGWB Chief Marketing Officer Ed Collins to launch the new shop.

DGWB, founded in 1988, currently is home to 90 staffers and serves clients such as HIlton Garden Inn, Wienerschnitzel, Toshiba, Dole, California Avocado Commission, Chicken of the Sea and Yogurtland. It has offices in both Santa Ana and Los Angeles. The shop will remain independent, while IPG still retains minority partnership in Amusement Park Entertainment.

-Read More- http://adage.com/article/agency-news/jimmy-smith-dgwb-partners-launch-am…

M·CAM releases Patently Obvious® on the Transformation of the Semiconductor Market

Date:  Mon, 2015-03-02

CHARLOTTESVILLE, VA March 2, 2015- M·CAM released its Patently Obvious® on the Transformation of the Semiconductor Market

In the late 1990s and early 2000s, semiconductor manufacturers patented thin, flexible printed circuit boards (PCB) and integrated circuits (IC), but did not have the technical means to implement these technologies. Today, the older patents in this space are newly relevant since more recent manufacturing capabilities will enable the wide array of advanced applications that are possible with thin, flexible semiconductors. Despite the fact that most of these patents are on OLEDs and LCDs, these technologies have wide-ranging applications which will transform markets such as 3G and 4G technology, wearable devices, intelligent sensors, and others.

M·CAM’s Patently Obvious® is a report providing visibility into potentially unconsidered alternatives, including art in the public domain, to patent holdings across a variety of technology areas.

M·CAM is a global, full-service intellectual property and rights (IP&R) and intangible asset financial services firm. We provide the technical and financial systems that allow public and private markets to use IP&R and IA for regulated transactions in banking, securities, insurance, and public innovation investment and technology procurement. From our pioneering work in creating the world’s first standards-based innovation collateralization financial products for banking and securities to our work in grassroots innovator enablement and patent quality assurance programs, M·CAM provides the mechanism to balance the interests of public and commercial sectors to support and build thriving economies.

The M·CAM Patently Obvious® on the Transformation of the Semiconductor Market can be found HERE.

eSurface enlists M·CAM to Serve as Strategic IP Market Analyst and Advisor

Date:  Wed, 2015-02-11

eSURFACE® TECHNOLOGIES TO EXPAND INTELLECTUAL PROPERTY IMPLEMENTATION

CARLSBAD, California ”· eSurface® Technologies (DBA of EarthOne Circuit Technologies Corporation, a privately-held corporation), the creator and licensor of the eSurface proprietary patented technology for applied conductive materials, today announced the enlistment of M·CAM International, LLC, as a strategic advisor in the areas of intellectual property (IP) and intangible assets (IA), use, value and implementation, effective immediately.

Under the signed agreement, M·CAM, through the use of their proprietary tools and core competencies, will support eSurface in providing a competitive advantage to its licensees and supply chain partners through the targeted application of eSurface’s intellectual properties. In this effort, M·CAM will provide an assessment of potential symbiotic patents, disclosures of know-how, business methods, and practices. From that process, eSurface and M·CAM will jointly identify discrete product development opportunities for specific potential customers, both domestically and in international markets.

“eSurface is one of a select class of companies that has developed a solution with the potential to solve multiple points of pain for many businesses in multiple industries,” stated Dave Martin, founder of M·CAM. “By committing resources to the fundamental re-imagination of how materials science, technological application, and industry performance can come together, eSurface has developed technologies that will put intelligence into products and industrial processes across a broad arc of industries. While they open entirely new technological advances on the one hand, their innovation will activate possibilities that were imagined years ago bringing state-of-the-art potential from the past into current reality.”

“We have always known the underpinnings of our technology had a tremendously wide potential application base,” explained David Benson, eSurface Chairman & CEO. “In the short term, we are completely changing the manufacturing paradigm for the electronics industry, but as significant as that is, it is truly the first step in how we will be using our IP to the benefit of our licensees moving forward. We believe the time is now for manufacturing to let go of the antiquated processes of the past and embrace the efficient, environmentally sustainable processes currently insisting on adoption. M·CAM is the perfect partner because they have the intellectual capital to understand the ramifications of where IP and IA can and should be leveraged and more importantly, they have creativity to imagine how various IP will work together.”

M·CAM International, LLC:

M·CAM is a global financial institution that advises corporations and investors on corporate finance and asset allocation by underwriting intellectual property (IP) and intangible assets (IA). From its roots in providing financial products enabling lenders to use IP and IA as regulatory acceptable collateral for lending, M·CAM’s capital solutions address the financial needs of businesses and investors in the Knowledge Economy.

M·CAM has been providing capital markets solutions to financial, sovereign, and corporate institutions since its inception in 1998. We work in over 160 countries. In addition to our commercial use across the global equity and debt markets, our platform has placed us as an advisor to help to set regulatory, audit, compliance and risk standards for intangible assets both domestically and internationally.

About eSurface Technologies:

eSurface® Technologies is the creator and licensor of eSurface, a proprietary patented technology that can dramatically impact the manufacturing and design segment of vast collection of industries seeking sustainable methods for embedding materials. The initial adoption of the eSurface proprietary technology by the global circuit board manufacturing industry is leading to the innovation of products previously not thought possible. eSurface Technologies (DBA of EarthOne Circuit Technologies Corporation, a privately-held corporation) is based in Carlsbad, California.

Contact:

Strategic Communications Rowland Hansonrhanson@eSurface.com

Investor Relations Doug Molyneuxdougmolyneux@eSurface.com

M·CAM releases Patently Obvious® on the IEEE Policy Update

Date:  Tue, 2015-02-10

CHARLOTTESVILLE, VA February 10, 2015- M·CAM released its Patently Obvious® on the IEEE Policy Update

Apple and Ericsson countersued each other when negotiations on a fair, reasonable, and non-discriminatory (FRAND) licensing agreement over Ericsson LTE patents went sour in January, 2015. The two companies have been negotiating on a new license for two years. This fight is one battle in the on-going war between “standard essential patent” (SEP) licensors and licensees. On February 8, 2015, the Board of Directors of the Institute of Electrical and Electronics Engineers (IEEE), a standard setting organization, approved an update to its patent licensing policy which could help avoid costly litigation, but some licensors are pushing back.

M·CAM’s Patently Obvious® is a report providing visibility into potentially unconsidered alternatives, including art in the public domain, to patent holdings across a variety of technology areas.

M·CAM is a global, full-service intellectual property and rights (IP&R) and intangible asset financial services firm. We provide the technical and financial systems that allow public and private markets to use IP&R and IA for regulated transactions in banking, securities, insurance, and public innovation investment and technology procurement. From our pioneering work in creating the world’s first standards-based innovation collateralization financial products for banking and securities to our work in grassroots innovator enablement and patent quality assurance programs, M·CAM provides the mechanism to balance the interests of public and commercial sectors to support and build thriving economies.

The M·CAM Patently Obvious® on the IEEE Policy Update can be found HERE.

Judiciary Chairman Bob Goodlatte Introduces Bipartisan Patent Reform Bill: The Innovation Act – HR 9

Date:  Thu, 2015-02-05

Our current patent laws are being abused in ways that are threatening the survival of American innovation. Today, Chairman Goodlatte introduced H.R. 9, the Innovation Act – a bipartisan bill that contains commonsense reforms and makes the patent litigation process more transparent. M·CAM supported H.R. 3309, the version of the bill which passed the House last Congress by a wide margin.

M·CAM worked with Chairman Goodlatte last Congress to help craft provisions on Real Party in Interest and other matters which are critical to the robust use of intellectual property in regulated banking transactions.

M·CAM looks forward to working with Chairman Goodlatte for a swift passage of this important legislation in 2015. For more information click HERE.